Delivery of basic fibroblast growth factor using heparin-conjugated fibrin for therapeutic angiogenesis

Tissue Engineering - Part A

Volumn 16, Issue 6, 2010, Pages 2113-2119

  Yang, Hee Seok ^a   Bhang, Suk Ho ^b   Hwang, Jin Wook ^a   Kim, Dong Ik ^c   Kim, Byung Soo ^b  

^a Hanyang University   (South Korea)

^b Seoul National University   (South Korea)

^c Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BIOACTIVITY; BIOMATERIALS; CELL CULTURE; FIBROBLASTS; GROWTH KINETICS; MUSCLE; PATHOLOGY; PEPTIDES;

BASIC FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; HIND LIMBS; HISTOLOGICAL ANALYSIS; HUMAN DERMAL FIBROBLASTS; IN-VITRO; ISCHEMIA MODEL; ISCHEMIC LIMBS; NEOVASCULARIZATION; THERAPEUTIC ANGIOGENESIS; THERAPEUTIC EFFICACY; THERAPEUTIC POTENTIALS; VASCULATURE DENSITY; WESTERN-BLOT ANALYSIS;

POLYSACCHARIDES;

MUS;

ANGIOGENIC FACTOR; FIBRIN; FIBROBLAST GROWTH FACTOR 2; HEPARIN;

ANGIOGENESIS; ANIMAL; ARTICLE; C57BL MOUSE; CHEMISTRY; DRUG EFFECT; FEMALE; HINDLIMB; HUMAN; IMMUNOHISTOCHEMISTRY; ISCHEMIA; METABOLISM; MOUSE; PATHOLOGY; WESTERN BLOTTING;

ANGIOGENESIS INDUCING AGENTS; ANIMALS; BLOTTING, WESTERN; FEMALE; FIBRIN; FIBROBLAST GROWTH FACTOR 2; HEPARIN; HINDLIMB; HUMANS; IMMUNOHISTOCHEMISTRY; ISCHEMIA; MICE; MICE, INBRED C57BL; NEOVASCULARIZATION, PHYSIOLOGIC;

EID: 77953345855     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2009.0673     Document Type: Article

References (20)

1. Sato, K., and Urist, M.R. Induced regeneration of calvaria by bone morphogenetic protein (BMP) in dogs. Clin Orthop Relat Res 197, 301, 1985.
2. Cai, S., Liu, Y., Zheng Shu, X., and Prestwich, G.D. Injectable glycosaminoglycan hydrogels for controlled release of human basic fibroblast growth factor. Biomaterials 26, 6054, 2005.
3. Hughes, G.C., Biswas, S.S., Yin, B., Coleman, R.E., DeGrado, T.R., Landolfo, C.K., Lowe, J.E., Annex, B.H., and Landolfo, K.P. Therapeutic angiogenesis in chronically ischemic porcine myocardium: comparative effects of bFGF and VEGF. Ann Thorac Surg 77, 812, 2004.
4. Zhong, Y., Zhang, L., Ding, A.G., Shenderova, A., Zhu, G., Pei, P., Chen, R.R., Mallery, S.R., Mooney, D.J., and Schwendeman, S.P. Rescue of SCID murine ischemic hind-limbs with pH-modified rhbFGF=Poly(DL-lactic-co-glycolic acid) implants. J Control Release 122, 331, 2007.
5. Jeon, O., Kang, S.W., Lim, H.W., Ji, H.C., and Kim, B.S. Long-term and zero-order release of basic fibroblast growth factor from heparin-conjugated poly(l-lactide-co-glycolide) nanospheres and fibrin gel. Biomaterials 27, 1598, 2006.
6. Jeon, O., Kang, S.W., Lim, H.W., Choi, D.H., Kim, D.I., Lee, S.H., Chung, J.H., and Kim, B.S. Synergistic effect of sustained delivery of basic fibroblast growth factor and bone marrow mononuclear cell transplantation on angiogenesis in mouse ischemic limbs. Biomaterials 27, 1617, 2006.
7. Cho, S.W., Gwak, S.J., Kang, S.W., Bhang, S.H., Song, K.W., Yang, Y.S., Choi, C.Y., and Kim, B.S. Enhancement of engiogenic efficacy of human cord blood cell transplantation. Tissue Eng 12, 1651, 2006.
8. Jeon, O., Ryu, S.H., Chung, J.H., and Kim, B.S. Control of basic fibroblast growth factor release from fibrin gel with heparin and concentrations of fibrinogen and thrombin. J Control Release 105, 249, 2005.
9. Sakiyama-Elbert, S.E., and Hubbell, J.A. Development of fibrin derivatives for controlled release of heparin-binding growth factors. J Control Release 65, 389, 2000.
10. Cho, S.W., Moon, S.H., Lee, S.H., Kang, S.W., Kim, J., Lim, J.M., Kim, H.S., Kim, B.S., and Chung, H.M. Improvement of postnatal neovascularization by human embryonic stem cell-derived endothelial-like cell transplantation in a mouse model of hindlimb ischemia. Circulation 116, 2409, 2007.
11. Jeon, O., Song, S.J., Yang, H.S., Kang, S.W., Bhang, S.H., Sung, M.A., Lee, J.H., and Kim, B.S. Long-term delivery enhances in vivo osteogenic efficacy of bone morphogenetic protein-2 compared to short-term delivery. Biochem Biophys Res Commun 369, 774, 2008.
12. Jeon, O., Song, S.J., Kang, S.W., Putnam, A.J., and Kim, B.S. Enhancement of ectopic bone formation by bone mor-phogenetic protein-2 released from a heparin-conjugated poly(L-lactic-co-glycolic acid) scaffold. Biomaterials 28, 2763, 2007.
13. Schaper, W., and Scholz, D. Factors regulating arteriogen-esis. Arterioscler Thromb Vasc Biol 23, 1143, 2003.
14. Tang, G.L., Chang, D.S., Sarkar, R., and Messina, L.M., The effect of gradual or acute arterial occlusion on skeletal muscle blood flow, arteriogenesis, and inflammation in rat hindlimb ischemia. J Vasc Surg 41, 312, 2005.
15. Boehm, U., Klamp, T., Groot, M., and Howard, J.C. Cellular responses to interferon-gamma. Annu Rev Immunol 15, 749, 1997.
16. Coughlin, C.M., Salhany, K.E., Gee, M.S., LaTemple, D.C., Kotenko, S., Ma, X., Gri, G., Wysocka, M., Kim, J.E., Lui, L., Liao, F., Farber, J.M., Pestka, S., Trinchieri, G., and Lee, W.M. Tumor cell responses to IFNgamma affect tumorigenicity and response to IL-12 therapy and antiangiogenesis. Immunity 9, 25, 1998.
17. Kitayama, J., Nagawa, H., Yasuhara, H., Tsuno, N., Kimura, W., Shibata, Y., and Muto, T. Suppressive effect of basic fibroblast growth factor on transendothelial emigration of CD4(\+) T-Lymphocyte. Cancer Res 54, 4729, 1994.
18. Dong, Z.M., Aplin, A.C., and Nicosia, R.F. Regulation of angiogenesis by macrophages, dendritic cells, and circulating myelomonocytic cells. Curr Pharm Des 15, 365, 2009.
19. Bhang, S.H., Kim, J.H., Yang, H.S., La, W.G., Lee, T.J., Sun, A.Y., Kim, G.H., Lee, M., and Kim, B.S. Combined delivery of heme oxigenase-1 gene and fibroblast growth factor-2 protein for therapeutic angiogenesis. Biomaterials 30, 6247, 2009.
20. Nugent, M.A., and Iozzo, R.V. Fibroblast growth factor-2. Int J Biochem Cell Biol 32, 115, 2000.